{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T22:56:04Z","timestamp":1740178564652,"version":"3.37.3"},"reference-count":7,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2019,3,20]],"date-time":"2019-03-20T00:00:00Z","timestamp":1553040000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,2,6]]},"DOI":"10.1093\/pch\/pxz023","type":"journal-article","created":{"date-parts":[[2019,3,20]],"date-time":"2019-03-20T22:00:32Z","timestamp":1553119232000},"page":"7-8","source":"Crossref","is-referenced-by-count":3,"title":["Skeletal fluorosis after prolonged voriconazole therapy"],"prefix":"10.1093","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7120-9408","authenticated-orcid":false,"given":"Isabelle","family":"Viel-Th\u00e9riault","sequence":"first","affiliation":[{"name":"Infectious Diseases Division, Department of Pediatrics, Children\u2019s Hospital of Eastern Ontario, Ottawa, Ontario"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrique","family":"Bittencourt","sequence":"additional","affiliation":[{"name":"Hematology-Oncology Division, Department of Pediatrics, CHU Sainte-Justine \u2013 Universit\u00e9 de Montr\u00e9al, Montr\u00e9al, Qu\u00e9bec"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Autmizguine","sequence":"additional","affiliation":[{"name":"Infectious Diseases Division, Department of Pediatrics, CHU Sainte-Justine \u2013 Universit\u00e9 de Montr\u00e9al, Montr\u00e9al, Qu\u00e9bec"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Ovetchkine","sequence":"additional","affiliation":[{"name":"Infectious Diseases Division, Department of Pediatrics, CHU Sainte-Justine \u2013 Universit\u00e9 de Montr\u00e9al, Montr\u00e9al, Qu\u00e9bec"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2019,3,20]]},"reference":[{"issue":"3","key":"2020120806133110600_CIT0001","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s10067-016-3341-7","article-title":"Voriconazole-induced periostitis: A new rheumatic disorder","volume":"36","author":"Adwan","year":"2017","journal-title":"Clin Rheumatol"},{"issue":"5","key":"2020120806133110600_CIT0002","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/pbc.25283","article-title":"Elevated fluoride levels and periostitis in pediatric hematopoietic stem cell transplant recipients receiving long-term voriconazole","volume":"62","author":"Tarlock","year":"2015","journal-title":"Pediatr Blood Cancer"},{"volume-title":"Fluorides: environmental health criteria 227","year":"2002","author":"Liteplo","key":"2020120806133110600_CIT0003"},{"issue":"Pt 5","key":"2020120806133110600_CIT0004","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1177\/0004563214568873","article-title":"Fluorosis and periostitis deformans as complications of prolonged voriconazole treatment","volume":"52","author":"Rad","year":"2015","journal-title":"Ann Clin Biochem"},{"issue":"9","key":"2020120806133110600_CIT0005","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1093\/cid\/ciu513","article-title":"Plasma fluoride level as a predictor of voriconazole-induced periostitis in patients with skeletal pain","volume":"59","author":"Moon","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"5","key":"2020120806133110600_CIT0006","doi-asserted-by":"crossref","first-page":"e12941","DOI":"10.1111\/tid.12941","article-title":"A vexing case of bone pain in a renal transplant recipient: Voriconazole-induced periostitis","volume":"20","author":"Poinen","year":"2018","journal-title":"Transpl Infect Dis"},{"issue":"12","key":"2020120806133110600_CIT0007","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1182\/blood-2012-01-403030","article-title":"Reversible skeletal disease and high fluoride serum levels in hematologic patients receiving voriconazole","volume":"120","author":"Gerber","year":"2012","journal-title":"Blood"}],"container-title":["Paediatrics & Child Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/pch\/article-pdf\/25\/1\/7\/34783777\/pxz023.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/pch\/article-pdf\/25\/1\/7\/34783777\/pxz023.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T22:01:49Z","timestamp":1607551309000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/pch\/article\/25\/1\/7\/5409718"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,20]]},"references-count":7,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,3,20]]},"published-print":{"date-parts":[[2020,2,6]]}},"URL":"https:\/\/doi.org\/10.1093\/pch\/pxz023","relation":{},"ISSN":["1205-7088","1918-1485"],"issn-type":[{"type":"print","value":"1205-7088"},{"type":"electronic","value":"1918-1485"}],"subject":[],"published-other":{"date-parts":[[2020,2]]},"published":{"date-parts":[[2019,3,20]]}}}